Companies House · 05486832

COLONIS PHARMA LIMITED

UK registered company, private limited company, incorporated 21 Jun 2005.

Active
40
Public contracts
0
Spend payments
Total spend

COLONIS PHARMA LIMITED is a UK company registered at Companies House under number 05486832. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
05486832
Status
Active
Company type
Private Limited Company
Incorporated
21 Jun 2005
Country of origin
United Kingdom
Registered office
25 BEDFORD SQUARE, BLOOMSBURY, LONDON, WC1B 3HH, UNITED KINGDOM
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Accounts category
AUDIT EXEMPTION SUBSIDIARY
View source on data.gov.uk

Public sector contracts

Contract awards linked to COLONIS PHARMA LIMITED.

ProcurementBuyerAwardedValue
NHS National Pharmaceuticals Transition 2022_2NHS England
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP30923 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood MedicineThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP35923 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Gastro Intestinal, Endocrine, Nutrition & Blood Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Psychiatry Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Proprietary DrugseTenderwales
NHS National Pharmaceuticals Transition 2021_3The NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals Transition 2021_3The NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals Transition 2021_3The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Generics Pharmaceuticals - Supply Chain ResilienceNHS England30 Apr 2026£4.2m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£403.7m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England4 Mar 2024£1
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Pharmaceuticals Transition 2022_2NHS England1 Nov 2022£35.7m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Pharmaceuticals Transition 2021_3NHS England21 Oct 2021£26m

Supplier identities

How this company appears as a supplier across the data.

FAQs about COLONIS PHARMA LIMITED

Is COLONIS PHARMA LIMITED an active company?

COLONIS PHARMA LIMITED (company number 05486832) is recorded as "Active", incorporated on 21 Jun 2005.

What does COLONIS PHARMA LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has COLONIS PHARMA LIMITED won UK public-sector contracts?

Yes — 40 public-sector contract awards are linked to this company in our data.

Where is COLONIS PHARMA LIMITED based?

Its registered office is 25 BEDFORD SQUARE, BLOOMSBURY, LONDON, WC1B 3HH, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable